High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside
NCT ID: NCT02943109
Last Updated: 2024-07-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3782 participants
INTERVENTIONAL
2016-12-31
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient-Centered Tablets: Applications for Inpatient Admissions
NCT02109601
Assessing Environmental Factors in Healthcare Facilities in Order to Improve the Experience of Patients, Staff, and the Quality of Imaging Procedures
NCT03456895
Space and Interaction Trial: Room Design and Patient-physician Interaction
NCT00806559
Incorporating Patient Capacity Into the Clinical Landscape
NCT02390570
Addressing Hospital Patient Information Needs Using Information Technology
NCT01970852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In response, this study supports the conduct of the first, large-scale randomized control trial (RCT) of the impact and use of an inpatient tablet-based patient portal embedded in a larger mixed methods study to examine changes in patient experiences and outcomes, and subsequent ambulatory patient portal usage. The investigators aim to study how access to a patient portal tailored to the inpatient stay can improve patient experience and increase patient engagement by improving patients' perception of the process of care while in the hospital (patient experience), increasing patients' self-efficacy for managing their chronic conditions (patient engagement), and facilitating use of a patient portal for care management activities after discharge (patient engagement).
The study site is a world-class healthcare facility with the ability to provide access to a patient portal designed specifically for the inpatient experience, bridging to outside the hospital after discharge.
Currently, this inpatient technology exists in only one other hospital in the US, but the investigators expect that as inpatient PHRs become more readily available, the need for clarity on this issue will only increase. The investigator's evaluation is a mixed-methods design consisting of primary data collection through surveys and interviews throughout the study period, and secondary data collection from the electronic health record and health system metadata. This study will offer insight into a potentially important mechanism to facilitate patient self-management.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High tech, high touch
Patient receives the full version of MyChart Bedside. Patient receives training/intervention from technology navigator
High Touch
Participants receives an in person visit from an "technology navigator" who helps to explain the technology to the patient.
High Tech
Patient receives full-suite access to an inpatient patient portal with bi-directional communication enabled.
Low tech, high touch
Patient receives the non-interactional version of MyChart Bedside. Patient receives training/intervention from technology navigator
High Touch
Participants receives an in person visit from an "technology navigator" who helps to explain the technology to the patient.
Low Tech
Patient receives a limited access version of the inpatient patient portal with bi-directional communication disabled.
High tech, low touch
Patient receives the full version of MyChart Bedside. Patient receives online training, only
Low Touch
Participants receives a visit from a "patient navigator" who helps to explain how to navigate the hospital system (active control).
High Tech
Patient receives full-suite access to an inpatient patient portal with bi-directional communication enabled.
Low tech, low touch
Patient receives the non-interactional version of MyChart Bedside. Patient receives online training, only
Low Touch
Participants receives a visit from a "patient navigator" who helps to explain how to navigate the hospital system (active control).
Low Tech
Patient receives a limited access version of the inpatient patient portal with bi-directional communication disabled.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Touch
Participants receives an in person visit from an "technology navigator" who helps to explain the technology to the patient.
Low Touch
Participants receives a visit from a "patient navigator" who helps to explain how to navigate the hospital system (active control).
High Tech
Patient receives full-suite access to an inpatient patient portal with bi-directional communication enabled.
Low Tech
Patient receives a limited access version of the inpatient patient portal with bi-directional communication disabled.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient available in their room
* capable of providing informed consent
Exclusion Criteria
* Patient was less than 18 years of age
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ann McAlearney
Professor of Family Medicine and Executive Director, CATALYST
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ann S McAlearney, ScD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ohio State University
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
McAlearney AS, Sieck CJ, Hefner JL, Aldrich AM, Walker DM, Rizer MK, Moffatt-Bruce SD, Huerta TR. High Touch and High Tech (HT2) Proposal: Transforming Patient Engagement Throughout the Continuum of Care by Engaging Patients with Portal Technology at the Bedside. JMIR Res Protoc. 2016 Nov 29;5(4):e221. doi: 10.2196/resprot.6355.
Walker DM, Hefner JL, MacEwan SR, Di Tosto G, Sova LN, Gaughan AA, Huerta TR, McAlearney AS. Differences by Race in Outcomes of an In-Person Training Intervention on Use of an Inpatient Portal: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Apr 1;7(4):e245091. doi: 10.1001/jamanetworkopen.2024.5091.
McAlearney AS, Walker DM, Sieck CJ, Fareed N, MacEwan SR, Hefner JL, Di Tosto G, Gaughan A, Sova LN, Rush LJ, Moffatt-Bruce S, Rizer MK, Huerta TR. Effect of In-Person vs Video Training and Access to All Functions vs a Limited Subset of Functions on Portal Use Among Inpatients: A Randomized Clinical Trial. JAMA Netw Open. 2022 Sep 1;5(9):e2231321. doi: 10.1001/jamanetworkopen.2022.31321.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.